![Abhinav Shukla](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Abhinav Shukla
Directeur Technique/Scientifique/R&D chez
SHATTUCK LABS, INC.
Fortune : 671 995 $ au 30/09/2026
Profil
Abhinav A. Shukla is currently Chief Technical Officer at Shattuck Labs, Inc. since 2021.
Former positions include Chief Technical Operations Officer at Redpin Therapeutics, Inc. (2020–2021), Vice President-Manufacturing at CRISPR Therapeutics AG (2019), VP & Head-Biologics Process Development at Shire Plc (2019), Senior VP-Process Development & Manufacturing at KBI Biopharma, Inc. (2011–2018), Principal Scientist at Amgen, Inc., and Director-Manufacturing Sciences & Technology at Bristol Myers Squibb Co. Education includes a doctorate from Rensselaer Polytechnic Institute and undergraduate and graduate degrees from Indian Institute of Technology New Delhi.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SHATTUCK LABS, INC. 0,1 % | 06/07/2026 | 98 533 ( 0,1 % ) | 671 995 $ | 30/09/2026 |
Postes actifs de Abhinav Shukla
| Sociétés | Poste | Début |
|---|---|---|
| SHATTUCK LABS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2021 |
Anciens postes connus de Abhinav Shukla
| Sociétés | Poste | Fin |
|---|---|---|
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders | Directeur Technique/Scientifique/R&D | 01/06/2021 |
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01/11/2019 |
| SHIRE | Corporate Officer/Principal | 01/11/2019 |
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Corporate Officer/Principal | 01/06/2018 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Abhinav Shukla
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology New Delhi
 Indian Institute of Technology New Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders | Commercial Services |
